Spyre Therapeutics, Inc. · NASDAQ:SYRE

Burrows Scott L sold 7,500 Spyre Therapeutics, Inc. shares (Form 4)

Traded Jun 1, 2026 · Filed Jun 3, 2026

On Jun 1, 2026, Burrows Scott L (Chief Financial Officer) sold 7,500 Spyre Therapeutics, Inc. shares at an average US$71.06 for US$533K under a trading plan, leaving 97,994 shares. Filed Jun 3, 2026 (Form 4).

Sold: 7,500 shares
Price: US$71.06 average (US$69.75 to US$72.06)
Value: US$533K
Holding after: 97,994 shares
Trading plan: Yes (Made under a plan set in advance)
Role: Chief Financial Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Jun 1, 2026	Common Stock	Option exercise	7,500	US$14.50	105,494	Direct
Jun 1, 2026	Common Stock	Sale	1,801	US$69.75	103,693	Direct
Jun 1, 2026	Common Stock	Sale	2,599	US$70.77	101,094	Direct
Jun 1, 2026	Common Stock	Sale	3,100	US$72.06	97,994	Direct

Source

View original at SEC

Related